Physician profile
Amy Renshaw
NPI 1528201688
$4,252.01
in general payments reported to CMS, 2019-2025
32 companies · $569 in 2025
The $569 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $182 · 2021: $479 · 2022: $994 · 2023: $819 · 2024: $787 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,001 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,000.59 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $855.83 | 2020-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $377.39 | 2023-2024 | Myfembree |
| Abbvie INC. | $339.69 | 2019-2023 | |
| Gynesonics, INC. | $336.56 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $283.31 | 2019-2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Channel Medsystems, INC. | $225.06 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $205.30 | 2022-2025 | |
| Therapeuticsmd, INC. | $191.48 | 2019-2022 | |
| Coopersurgical, INC. | $185.83 | 2019-2024 | Paragard T 380a, Supercut Hysterectomy Scissors |
| Gen-Probe Sales & Service, INC. | $164.49 | 2022 | |
| Sage Therapeutics, LLC | $140.57 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $89.37 | 2022-2025 | Slynd |
| Shield Therapeutics INC | $82.20 | 2023-2024 | Accrufer |
| Merck Sharp & Dohme LLC | $80.97 | 2020-2025 | Gardasil 9 |
| Organon LLC | $78.34 | 2022-2025 | Nexplanon |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $69.92 | 2022-2024 | Contrave |
| Exact Sciences Corporation | $66.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $61.22 | 2019-2025 | |
| Novo Nordisk INC | $49.90 | 2023-2024 | Wegovy |
| Millicent US INC | $47.71 | 2025 | Intrarosa, Femlyv |
| Pfizer INC. | $44.57 | 2021-2023 | |
| Ethicon US, LLC | $40.27 | 2022 | |
| Baxter Healthcare | $37.22 | 2023-2025 | Perclot, Floseal |
| Amgen INC. | $32.87 | 2019-2021 | |
| Evofem Biosciences, INC. | $31.89 | 2021-2022 | |
| Lilly USA, LLC | $28.68 | 2024-2025 | Zepbound |
| Alexion Pharmaceuticals, INC. | $22.05 | 2025 | Ultomiris |
| Agile Therapeutics, INC. | $18.49 | 2022 | |
| Medtronic Minimed, INC. | $18.18 | 2019 | |
| Smith+Nephew, INC. | $17.38 | 2019 | |
| Lupin INC. | $15.90 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Renshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.